Home/ Supplements/ Melatonin/ Melatonin 10 mg

Melatonin 10 mg

product on market Tablet or Pill EuroMedica Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Melatonin 10 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
60
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

EP120
10 mg

Other Ingredients

Sucrose Microcrystalline Cellulose Hydroxypropyl Methylcellulose Stearic Acid Maltodextrin Magnesium Stearate Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommendations: 1 tablet, 1-2 hours before bedtime, or as directed by your healthcare practitioner.

Warnings & Precautions

Occasional inflammation due to exercise or overuse.

If pregnant or nursing, consult a healthcare practitioner before use.

May cause drowsiness. Do not take when operating machinery or driving a vehicle.

Formulation Notes

Melatonin is predominantly known for promoting restful sleep cycles, and because melatonin is such a powerful antioxidant it also plays a huge role in supporting cellular health. Healthy inflammation response Promotes healthy sleep cycles Supports cellular health

Healthy immune function

Vegan

Non-GMO No salt, yeast, wheat, gluten, soy, diary products, artificial coloring, artificial flavoring or artificial preservatives.

Metadata

Product Details

UPC / SKU3 67703 61946 6
DSLD Entry Date2022-04-11
Product TypeNon-Nutrient/Non-Botanical
FormTablet or Pill
DSLD ID261535
Data Updated2026-04-11
Research

Research Evidence

291
Research Sources
55
Avg Quality
129
Meta Analysis
93
Systematic Review
51
Rct
11
Clinical Trial
2
Other
2
Regulatory Source
1
Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022 PubMed DOI
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022 PubMed DOI
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022 PubMed DOI
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023 PubMed DOI
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Melatonin →
Compare

Similar Products

View all Melatonin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.